Loss of locus coeruleus neurons and reduced startle in parkin null mice - PubMed (original) (raw)
Loss of locus coeruleus neurons and reduced startle in parkin null mice
Rainer Von Coelln et al. Proc Natl Acad Sci U S A. 2004.
Abstract
Parkinson's disease (PD) is the most common neurodegenerative movement disorder and is characterized pathologically by degeneration of catecholaminergic neurons of the substantia nigra pars compacta and locus coeruleus, among other regions. Autosomal-recessive juvenile Parkinsonism (ARJP) is caused by mutations in the PARK2 gene coding for parkin and constitutes the most common familial form of PD. The majority of ARJP-associated parkin mutations are thought to be loss of function-mutations; however, the pathogenesis of ARJP remains poorly understood. Here, we report the generation of parkin null mice by targeted deletion of parkin exon 7. These mice show a loss of catecholaminergic neurons in the locus coeruleus and an accompanying loss of norepinephrine in discrete regions of the central nervous system. Moreover, there is a dramatic reduction of the norepinephrine-dependent startle response. The nigrostriatal dopaminergic system does not show any impairment. This mouse model will help gain a better understanding of parkin function and the mechanisms underlying parkin-associated PD.
Figures
Fig. 1.
Targeted deletion of parkin exon 7 in the mouse genome results in the absence of parkin protein. (A) Schematic representation of the targeting strategy. (B) Southern blot of genomic DNA from WT mice (+/+) and mice heterozygous (+/-) or homozygous (-/-) for the exon 7-deleted allele. _Hae_III-digested DNA was hybridized with the probe represented in A. (C) RT-PCR with nested primers flanking exon 7. cDNA from one WT and one parkin null mouse was used as a template for PCR amplification by using primer pair A or B. (D) Northern blot of poly(A) RNA. A probe spanning exons 1–5 was used for hybridization. (E) Western blot of whole-brain lysates with a parkin-specific antibody (PRK8), demonstrating reduced expression of parkin protein in heterozygous mice and its absence in parkin null mice.
Fig. 2.
Behavioral analysis: reduced acoustic startle in parkin null mice. (A) Open field test. (B) Rotarod. (C) Acoustic startle. Data are expressed as mean ± SEM. *, P < 0.05; **, P < 0.01, analyzed by two-tailed t test.
Fig. 3.
Loss of TH-IR in the LC, but not SNpc or striatum of parkin null mice. Immunohistochemical staining for TH (C–F: with Nissl counterstain) was performed on coronal brain sections from WT (A, C, and E) and parkin KO (B, D, and F) mice. (A and B) Striatum. (C and D) Midbrain with SN and ventral tegmental area. (E and F) LC. (Insets) A lower magnification of the same sections to verify that both pictures represent equivalent planes. (All bars = 200 μm.)
Fig. 4.
Stereological analysis of reduced number of TH-positive LC neurons in parkin null mice. (A) Number of TH-positive and Nissl-positive neurons in the SNpc of aged (12- and 18-month-old) WT and parkin KO mice. (B) Number of TH-positive LC neurons in young (2-month-old) and aged (12- and 18-month-old) parkin null mice and age-matched controls. Data are expressed as mean ± SEM. *, P < 0.05, analyzed by two-tailed t test.
Fig. 5.
Reduced NE levels in discrete CNS regions of parkin null mice. Concentrations of catecholamines were determined by HPLC with electrochemical detection. (A) Striatal levels of dopamine (DA) and its metabolites. (B) Concentration of NE in discrete CNS regions of WT and parkin null mice. Data are expressed as mean ± SEM. *, P < 0.05, analyzed by two-tailed t test.
Similar articles
- MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
Thomas B, von Coelln R, Mandir AS, Trinkaus DB, Farah MH, Leong Lim K, Calingasan NY, Flint Beal M, Dawson VL, Dawson TM. Thomas B, et al. Neurobiol Dis. 2007 May;26(2):312-22. doi: 10.1016/j.nbd.2006.12.021. Epub 2007 Jan 25. Neurobiol Dis. 2007. PMID: 17336077 Free PMC article. - Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.
Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R. Wang HQ, et al. J Neurochem. 2008 Oct;107(1):171-85. doi: 10.1111/j.1471-4159.2008.05607.x. Epub 2008 Aug 7. J Neurochem. 2008. PMID: 18691389 - Dopamine covalently modifies and functionally inactivates parkin.
LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. LaVoie MJ, et al. Nat Med. 2005 Nov;11(11):1214-21. doi: 10.1038/nm1314. Epub 2005 Oct 16. Nat Med. 2005. PMID: 16227987 - [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N. Hattori N. Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Rinsho Shinkeigaku. 2004. PMID: 15287506 Review. Japanese. - The synaptic function of parkin.
Sassone J, Serratto G, Valtorta F, Silani V, Passafaro M, Ciammola A. Sassone J, et al. Brain. 2017 Sep 1;140(9):2265-2272. doi: 10.1093/brain/awx006. Brain. 2017. PMID: 28335015 Review.
Cited by
- Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
Guo M. Guo M. Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a009944. doi: 10.1101/cshperspect.a009944. Cold Spring Harb Perspect Med. 2012. PMID: 23024178 Free PMC article. Review. - Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.
Ko HS, von Coelln R, Sriram SR, Kim SW, Chung KK, Pletnikova O, Troncoso J, Johnson B, Saffary R, Goh EL, Song H, Park BJ, Kim MJ, Kim S, Dawson VL, Dawson TM. Ko HS, et al. J Neurosci. 2005 Aug 31;25(35):7968-78. doi: 10.1523/JNEUROSCI.2172-05.2005. J Neurosci. 2005. PMID: 16135753 Free PMC article. - Parkin is protective against proteotoxic stress in a transgenic zebrafish model.
Fett ME, Pilsl A, Paquet D, van Bebber F, Haass C, Tatzelt J, Schmid B, Winklhofer KF. Fett ME, et al. PLoS One. 2010 Jul 30;5(7):e11783. doi: 10.1371/journal.pone.0011783. PLoS One. 2010. PMID: 20689587 Free PMC article. - Toxin-induced and genetic animal models of Parkinson's disease.
Hisahara S, Shimohama S. Hisahara S, et al. Parkinsons Dis. 2010 Dec 22;2011:951709. doi: 10.4061/2011/951709. Parkinsons Dis. 2010. PMID: 21234368 Free PMC article. - Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain.
Kageyama Y, Hoshijima M, Seo K, Bedja D, Sysa-Shah P, Andrabi SA, Chen W, Höke A, Dawson VL, Dawson TM, Gabrielson K, Kass DA, Iijima M, Sesaki H. Kageyama Y, et al. EMBO J. 2014 Dec 1;33(23):2798-813. doi: 10.15252/embj.201488658. Epub 2014 Oct 27. EMBO J. 2014. PMID: 25349190 Free PMC article.
References
- Lang, A. E. & Lozano, A. M. (1998) N. Engl. J. Med. 339, 1044-1053. - PubMed
- Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N. & Braak, E. (2003) Neurobiol. Aging 24, 197-211. - PubMed
- Zarow, C., Lyness, S. A., Mortimer, J. A. & Chui, H. C. (2003) Arch. Neurol. 60, 337-341. - PubMed
- Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. & Goedert, M. (1997) Nature 388, 839-840. - PubMed
- Lim, K. L., Dawson, V. L. & Dawson, T. M. (2002) Curr. Neurol. Neurosci. Rep. 2, 439-446. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous